Trimarchi Thomas
SEC CIK 2030813 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | Pres, COO | 336.5K | — | $5.99M | 19 | 2024-08-06 | 2026-08-16 |
Most active insiders at BBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kumar Neil | CEO, Dir | — | $61.54M |
| 2 | Cook Jennifer E. | Dir | — | $21.92M |
| 3 | MCCORMICK FRANK | Dir | — | $13.31M |
| 4 | Lo Andrew | Dir | — | $6.32M |
| 5 | Ellis Andrea | Dir | — | $5.65M |
| 6 | Valantine Hannah | Dir | — | $4.37M |
| 7 | DANIELS RONALD J | Dir | — | $3.89M |
| 8 | Trimarchi Thomas | Pres, CFO | — | $3.03M |
| 9 | Scott Randal W. | Dir | — | $2.09M |
| 10 | Apuli Maricel | CAO | — | $621.7K |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 18:02 | 2026-08-16 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | F - Tax | $79.86 | -22.8K | 336.5K | -6% | -$1.82M | |
| T | 2026-05-19 16:30 | 2026-05-16 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | F - Tax | $66.13 | -22.8K | 372.8K | -6% | -$1.51M |
| MT | 2026-05-19 16:30 | 2026-05-18 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | S - Sale | $65.08 | -13.7K | 359.2K | -4% | -$888.4K |
| 2026-03-20 | 2026-03-18 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | A - Grant | $0.00 | +59.0K | 395.6K | +18% | $0 | |
| 2026-02-18 | 2026-02-16 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | F - Tax | $75.25 | -18.8K | 350.2K | -5% | -$1.42M | |
| M | 2026-02-18 | 2026-02-17 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | S - Sale | $74.72 | -13.6K | 336.8K | -4% | -$1.02M |
| 2025-12-16 | 2025-12-12 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | F - Tax | $75.15 | -13.8K | 369.0K | -4% | -$1.04M | |
| 2025-11-18 | 2025-11-16 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | F - Tax | $66.39 | -21.3K | 399.8K | -5% | -$1.42M | |
| M | 2025-11-18 | 2025-11-17 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | S - Sale | $66.46 | -16.9K | 389.8K | -4% | -$1.13M |
| 2025-08-22 | 2025-08-21 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | S - Sale | $49.48 | -42.2K | 421.1K | -9% | -$2.09M | |
| T | 2025-08-19 | 2025-08-16 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | F - Tax | $51.32 | -21.3K | 480.7K | -4% | -$1.09M |
| MT | 2025-08-19 | 2025-08-18 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | S - Sale | $50.23 | -17.4K | 463.3K | -4% | -$871.7K |
| 2025-05-20 | 2025-05-16 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | F - Tax | $33.84 | -21.3K | 502.0K | -4% | -$721.4K | |
| 2025-03-21 | 2025-03-19 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, CFO | A - Grant | $0.00 | +109.1K | 523.3K | +26% | $0 | |
| 2025-02-19 | 2025-02-16 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, COO | F - Tax | $34.90 | -13.8K | 414.2K | -3% | -$481.0K | |
| 2024-12-12 | 2024-12-10 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, COO | A - Grant | $0.00 | +50.0K | 428.0K | +13% | $0 | |
| 2024-11-19 | 2024-11-16 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, COO | F - Tax | $23.72 | -17.9K | 378.0K | -5% | -$425.4K | |
| 2024-08-20 | 2024-08-16 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, COO | F - Tax | $24.40 | -17.9K | 395.9K | -4% | -$437.6K | |
| D | 2024-08-08 | 2024-08-06 | BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | Pres, COO | A - Grant | $0.00 | +19.0K | 413.9K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations